Mathematical modeling of interaction between innate and adaptive immune responses in COVID‐19 and implications for viral pathogenesis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
We have applied mathematical modeling to investigate the infections of the ongoing coronavirus disease‐2019 (COVID‐19) pandemic caused by SARS‐CoV‐2 virus. We first validated our model using the well‐studied influenza viruses and then compared the pathogenesis processes between the two viruses. The interaction between host innate and adaptive immune responses was found to be a potential cause for the higher severity and mortality in COVID‐19 patients. Specifically, the timing mismatch between the two immune responses has a major impact on disease progression. The adaptive immune response of the COVID‐19 patients is more likely to come before the peak of viral load, while the opposite is true for influenza patients. This difference in timing causes delayed depletion of vulnerable epithelial cells in the lungs in COVID‐19 patients while enhancing viral clearance in influenza patients. Stronger adaptive immunity in COVID‐19 patients can potentially lead to longer recovery time and more severe secondary complications. Based on our analysis, delaying the onset of adaptive immune responses during the early phase of infections may be a potential treatment option for high‐risk COVID‐19 patients. Suppressing the adaptive immune response temporarily and avoiding its interference with the innate immune response may allow the innate immunity to more efficiently clear the virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · cited 1×
“The median time from symptoms to discharge from the hospital was about 22 days, whereas the median time to death was 18 days.(4) Among this study of 191 patients, the shortest observed duration of viral shedding among survivors was 8 days, whereas the longest was 37 days.”
BackgroundChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148 · cited 1×
“Another indication is that a large number of patients with CT scans showing ground‐glass opacity do not necessarily have severe COVID‐19 symptoms.(2) In influenza infections, most of the patients experience total depletion of target cells and recover without any consequences.”
BackgroundLa certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575 · cited 1×
“The mean incubation period for COVID‐19 patients is estimated to be 6 days, with a range distribution of 13 days.(14,15) The median time from symptoms to discharge from the hospital was about 22 days, whereas the median time to death was 18 days.”
BackgroundHamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 1×
“Previous studies have investigated the RNA expression of ACE2 in 72 human tissues.(9) Two more recent studies have shown that the percentage of epithelial cells with ACE2 receptors in bronchial is much lower than in turbinate and lung tissues (0.”
BackgroundXu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1637-5 · Cited by 2,205 · cited 1×
“Similarly, the SARS‐CoV‐2 virus binds to the angiotensin‐converting enzyme 2 (ACE2) receptors on the surface epithelial cells.(8) These cells with ACE2 expression are hence vulnerable to virus attack and are called target cells in mathematical models.”
BackgroundHepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J., & Perelson, A. S. (1998) · Science · doi:10.1126/science.282.5386.103 · Cited by 2,113
IMMUNOBIOLOGY : the immunesystem in health and disease
Janeway, C. A. (1994) · Cited by 1,757
Backer, J. A., Klinkenberg, D., & Wallinga, J. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.5.2000062 · Cited by 1,500
Population Dynamics of Immune Responses to Persistent Viruses
Nowak, M. A., & Bangham, C. R. M. (1996) · Science · doi:10.1126/science.272.5258.74 · Cited by 1,277
Viral dynamics in hepatitis B virus infection.
Nowak, M. A., Bonhoeffer, S., Hill, A. M., Boehme, R., Thomas, H. C., & McDade, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4398 · Cited by 1,045
Virus dynamics: Mathematical principles of immunology and virology
Nowak, M. A., & May, R. M. (2001) · Cited by 934
Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2
Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · doi:10.1101/2020.01.26.919985 · Cited by 860 · cited 1×
“2% vs 2–3%).(10,11) Considering the difference in surface area between the lungs and the nasal cavity,31‐33 we arrived at a rough estimate of 104 as the ratio of target cells in these two organs.”
BackgroundH5N1 Virus Attachment to Lower Respiratory Tract
van Riel, D., Munster, V. J., de Wit, E., Rimmelzwaan, G. F., Fouchier, R. A. M., Osterhaus, A. D. M. E., & Kuiken, T. (2006) · Science · doi:10.1126/science.1125548 · Cited by 691
Virus dynamics and drug therapy
Bonhoeffer, S., May, R. M., Shaw, G. M., & Nowak, M. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6971 · Cited by 632
Cell-mediated Protection in Influenza Infection
Thomas, P. G., Keating, R., Hulse-Post, D. J., & Doherty, P. C. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1201.051237 · Cited by 466
Zhao, Z. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05320-0 · Cited by 407 · cited 1×
“Immunosuppressants such as corticosteroids have been applied to SARS and COVID‐19 patients, with positive results.(29,30) From the previous discussions, we propose a potential treatment plan by applying immunosuppressive drugs as soon as an infection is detected in the lungs, and remove the drug as soon as the target…”
BackgroundInfluenza and the challenge for immunology
Doherty, P. C., Turner, S. J., Webby, R. G., & Thomas, P. G. (2006) · Nature Immunology · doi:10.1038/ni1343 · Cited by 356
Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract
Nicholls, J. M., Chan, M. C. W., Chan, W. Y., Wong, H. K., Cheung, C. Y., Kwong, D. L. W., Wong, M. P., Chui, W. H., Poon, L. L. M., Tsao, S. W., et al. (2007) · Nature Medicine · doi:10.1038/nm1529 · Cited by 341 · cited 1×
“In very severe, and often fatal cases of influenza, the infection will spread to the lower lungs.(6,7) Similarly, the SARS‐CoV‐2 virus binds to the angiotensin‐converting enzyme 2 (ACE2) receptors on the surface epithelial cells.”
BackgroundCiliated epithelial cell lifespan in the mouse trachea and lung
Rawlins, E. L., & Hogan, B. L. M. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90209.2008 · Cited by 301
Mathematical models of HIV pathogenesis and treatment
Wodarz, D., & Nowak, M. A. (2002) · BioEssays · doi:10.1002/bies.10196 · Cited by 299
Defense Mechanisms against Influenza Virus Infection in the Respiratory Tract Mucosa
Tamura, S.-I., & Kurata, T. (2004) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2004.236 · Cited by 276 · cited 2×
“Other components like IgA, CD4 T cells, and a number of other components of the AIR could also play important roles here.(13) Although we have used the three components of CD8 and antibodies of IgM and IgG as a representation of the AIR, our conclusions are more general.”
BackgroundMethodAnatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery
Gizurarson, S. (2012) · Current Drug Delivery · doi:10.2174/156720112803529828 · Cited by 263
Beauchemin, C. A., & Handel, A. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-s1-s7 · Cited by 242 · cited 3×
“The eclipse phase is reported to be around 6 hours, with viral load peaks around 2 to 3 days postinfection (dpi).(5) The infection typically resolves in 3 to 5 days.”
BackgroundInfluentialMiao, H., Hollenbaugh, J. A., Zand, M. S., Holden-Wiltse, J., Mosmann, T. R., Perelson, A. S., Wu, H., & Topham, D. J. (2010) · Journal of Virology · doi:10.1128/jvi.00266-10 · Cited by 223
Wang, Y., Jiang, W., He, Q., Wang, C., Liu, B., Zhou, P., Dong, N., & Tong, Q. (2020) · medRxiv · doi:10.1101/2020.03.06.20032342 · Cited by 184 · cited 1×
“Immunosuppressants such as corticosteroids have been applied to SARS and COVID‐19 patients, with positive results.(29,30) From the previous discussions, we propose a potential treatment plan by applying immunosuppressive drugs as soon as an infection is detected in the lungs, and remove the drug as soon as the target…”
BackgroundPathogenesis of emerging avian influenza viruses in mammals and the host innate immune response
Maines, T. R., Szretter, K. J., Perrone, L., Belser, J. A., Bright, R. A., Zeng, H., Tumpey, T. M., & Katz, J. M. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00690.x · Cited by 174
Wu, C., Zheng, S., Chen, Y., & Zheng, M. (2020) · medRxiv · doi:10.1101/2020.02.11.20022228 · Cited by 103 · cited 1×
“2% vs 2–3%).(10,11) Considering the difference in surface area between the lungs and the nasal cavity,31‐33 we arrived at a rough estimate of 104 as the ratio of target cells in these two organs.”
BackgroundZitzmann, C., & Kaderali, L. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01546 · Cited by 94
Regeneration of the Aging Lung: A Mini-Review
Navarro, S., & Driscoll, B. (2016) · Gerontology · doi:10.1159/000451081 · Cited by 74 · cited 1×
“Could this be the reason for the observed higher severity rate among older patients? We reason that this is not likely, as the cell regeneration rate should be higher for younger patients, while older people are known to have more difficulty repairing lung damage.(35) In this article, we have applied the target cell‐l…”
BackgroundWu, Y., Hou, B., Liu, J., Chen, Y., & Zhong, P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00315 · Cited by 73
Effects of Antirejection Drugs on Innate Immune Cells After Kidney Transplantation
Zaza, G., Leventhal, J. S., Signorini, L. F., Gambaro, G., & Cravedi, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02978 · Cited by 54 · cited 1×
“done on the effects of the drugs on different parts of immune response.(27,28) The goal of investigating immunosuppressive drugs is to explore their possible applications in COVID‐19 disease management.”
BackgroundThe Case for Why Africa Should Host COVID-19 Candidate Vaccine Trials
Singh, J. A. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa303 · Cited by 21
Cited by
Bajaj, V., Gadi, N., Spihlman, A. P., Wu, S. C., Choi, C. H., & Moulton, V. R. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.571416 · Cited by 476
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
Rodríguez, Y., Novelli, L., Rojas, M., De Santis, M., Acosta-Ampudia, Y., Monsalve, D. M., Ramírez-Santana, C., Costanzo, A., Ridgway, W. M., Ansari, A. A., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102506 · Cited by 312
Metadata
- Authors
- Du, S. Q., & Yuan, W.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 2020-05-13
- Volume
- 92
- Issue
- 9
- Pages
- 1615-1628
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W3021634238
- Cited by
- 183
- References
- 35
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.